Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian
French theme park firm won UK government support despite far-right ties
19/10/2025
50 women’s autumn wardrobe updates for under £300 (some are even free)
19/10/2025
‘The wire began to smoke’ : how to avoid counterfeit scams on Vinted and other resale sites
19/10/2025
We cycled 2,000 miles from Cornwall to Portugal – with surfboards in tow
19/10/2025
Xi Jinping is preparing to go toe to toe with Donald Trump – and there will only be one winner | Simon Tisdall
19/10/2025
Campaigners urge CPS to reconsider charges against partner of woman who died by suicide
19/10/2025